7 Geographic Atrophy Clinical Trials in St. Petersburg, FL (2026)

Q: How do I join a clinical trial in St. Petersburg?

Browse available studies, click one that interests you, and complete the free eligibility form. A study coordinator at the St. Petersburg research site will contact you.

Recruiting Geographic Atrophy Studies in St. Petersburg

NCT07221149Recruiting

A Study to Evaluate the Safety and Efficacy of Pumitamig in Combination With Chemotherapy Versus Nivolumab in Combination With Chemotherapy in Participants With Previously Untreated Advanced or Metastatic Gastric, Gastroesophageal Junction, or Esophageal Adenocarcinoma (ROSETTA Gastric-204)

The purpose of this study is to evaluate the safety and efficacy of Pumitamig in combination with chemotherapy versus Nivolumab in combination with chemotherapy in participants with previously untreat...

St. Petersburg, FLPHASE2690 participantsBristol-Myers Squibb

View Study Details

NCT06532006Recruiting

A Phase Ⅲ Clinical Study of HLX22 in Combination With Trastuzumab and Chemotherapy for the Treatment of Gastroesophageal Junction and Gastric Cancer

This is a double-blind, randomized, multiregion, comparative phase Ⅲ clinical study designed to evaluate the efficacy and safety of HLX22 in combination with trastuzumab and chemotherapy as first-line...

St. Petersburg, FLPHASE3550 participantsShanghai Henlius Biotech

View Study Details

NCT06230185Recruiting

CtDNA Based MRD Testing for NAC Monitoring in TNBC

A prospective, multicenter, observational study to evaluate the correlation of Molecular Residual Disease (MRD) detection using circulating tumor DNA guided test to pathological complete response (pCR...

St. Petersburg, FL422 participantsPersonalis Inc.

View Study Details

NCT03827694Recruiting

Non-Invasive Diagnosis of Pediatric Pulmonary Invasive Mold Infections

This study will establish a non-invasive diagnostic approach and evaluate clinical outcomes for children at high-risk for pulmonary invasive fungal infection (PIFI)....

St. Petersburg, FL400 participantsArkansas Children's Hospital Research Institute

View Study Details

NCT07441642Recruiting

A Study to Investigate Efficacy and Safety of FWY003 Compared With Placebo in Participants With Geographic Atrophy Secondary to Age-related Macular Degeneration

To characterize the dose response relationship of FWY003 in participants with geographic atrophy (GA) secondary to age-related macular degeneration (AMD)....

St. Petersburg, FLPHASE2272 participantsNovartis Pharmaceuticals

View Study Details

NCT07215234Recruiting

A Safety and Efficacy Study of a One-time Intravitreal Injection of SAR446597 in Participants With Geographic Atrophy Secondary to Age-related Macular Degeneration

This is a sequential Phase 1/2, two-part, multicenter study on safety, tolerability, and efficacy of one-time intravitreal SAR446597 for the treatment of participants with Geographic Atrophy (GA) seco...

St. Petersburg, FLPHASE1104 participantsSanofi

View Study Details

NCT05319353Recruiting

A Study to Evaluate the Safety and Tolerability, Pharmacokinetics, and Antiviral Activity of Maribavir for the Treatment of Cytomegalovirus (CMV) Infection in Children and Adolescents Who Have Received a Hematopoietic Stem Cell Transplant (HSCT) or a Solid Organ Transplant (SOT)

The main aim of this study is to find out the safety, tolerability and pharmacokinetics (PK) of maribavir for the treatment of CMV infection in children and teenagers after HSCT or SOT and to identify...

St. Petersburg, FLPHASE380 participantsTakeda

View Study Details

About Geographic Atrophy Clinical Trials in St. Petersburg

Geographic atrophy is the advanced form of dry age-related macular degeneration, involving progressive loss of retinal cells. It leads to enlarging blind spots in central vision. Recently approved complement inhibitor therapies can slow progression.

There are currently 7 geographic atrophy clinical trials recruiting participants in St. Petersburg, FL. These studies are seeking a combined 2,518 participants. Research is being sponsored by Bristol-Myers Squibb, Shanghai Henlius Biotech, Personalis Inc. and 4 other organizations. Clinical trial participation is free and participants receive study-related medical care at no cost.

Geographic Atrophy Clinical Trials in St. Petersburg — FAQ

Are there geographic atrophy clinical trials in St. Petersburg?

Yes, there are 7 geographic atrophy clinical trials currently recruiting in St. Petersburg, FL. Browse the studies on this page to find one that fits.

How do I join a clinical trial in St. Petersburg?

Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the St. Petersburg research site will contact you about next steps.

Are clinical trials in St. Petersburg free?

Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many St. Petersburg studies also compensate for your time and travel.

What geographic atrophy treatments are being tested?

The 7 active trials in St. Petersburg are testing new therapies including novel drugs, biologics, and treatment approaches for geographic atrophy.

Data updated July 22, 2026 from ClinicalTrials.gov